Related Experiment Video

Updated: Jul 16, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Cytokine-producing sarcoma mimics eosinophilic leukaemia

Jun Ando, Koichi Sugimoto, Kenji Tamayose

    European Journal of Haematology
    |March 3, 2007
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
    11:42

    Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

    Published on: April 7, 2017

    Related Experiment Videos

    Last Updated: Jul 16, 2026

    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
    07:18

    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

    Published on: June 13, 2019

    Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
    11:42

    Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

    Published on: April 7, 2017

    Related Concept Videos

    Rous Sarcoma Virus (RSV) and Cancer01:03

    Rous Sarcoma Virus (RSV) and Cancer

    Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
    RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
    Rous Sarcoma Virus (RSV) and Cancer01:03

    Rous Sarcoma Virus (RSV) and Cancer

    Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
    RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

    Articles linked to this work by shared authors, journal, and citation graph.

    Vitamin B6 deficiency as a cause of erythropoietin-stimulating agent-resistant anemia in hemodialysis patients: A report of two cases.

    Internal medicine (Tokyo, Japan)·2026

    Prognostic impact of KMT2A-PTD in acute myeloid leukemia in the NGS era: a multicenter retrospective study.

    Annals of hematology·2026

    Long-term real-world effectiveness and safety of edoxaban in chronic thromboembolic pulmonary hypertension: a nationwide registry study.

    Journal of thrombosis and haemostasis : JTH·2026

    Differential impact of host-related factors on survival outcomes between IO+IO and IO+TKI in metastatic renal cell carcinoma: a multicenter retrospective study.

    International journal of clinical oncology·2026

    TFH phenotype and response to tucidinostat in relapsed/refractory PTCL: analysis of patients from a phase IIb trial.

    International journal of hematology·2026

    Metabolic engineering of tomato fruits for production of raspberry ketone glycosides.

    Journal of biotechnology·2026

    Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases.

    European journal of haematology·2026

    SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver.

    European journal of haematology·2026

    Hyperferritinemia: Pathophysiology, Etiologies, and Diagnostic Approach.

    European journal of haematology·2026

    Longitudinal Molecular Characterization of a Rare TPM3::PDGFRB-Rearranged Myeloid/Lymphoid Neoplasm With Late CNL-Like Neutrophilic Evolution.

    European journal of haematology·2026

    The Myeloma Risk Variant of TNFRSF13B Shows Reduced NF-κB Signalling Activity in HEK293 Cells.

    European journal of haematology·2026

    Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants.

    European journal of haematology·2026

    Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer.

    Cancer research·2026

    Synchronous Papillary Thyroid Carcinoma and an Angiomatoid Fibrous Histiocytoma: A Rare, Interesting Case Report.

    Cureus·2026

    Hyalinizing Trabecular Tumor of the Thyroid Gland: A Diagnostic and Surgical Challenge.

    Cureus·2026

    Neural regulation of immune evasion in breast cancer: a multiscale neuro-immune framework.

    Frontiers in immunology·2026

    Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer.

    Frontiers in immunology·2026

    Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.

    Cancer cell·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us